Loading...
Promotion of joint degeneration and chondrocyte metabolic dysfunction by excessive growth hormone in mice
Zhu, S. Liu, H. Davis, T. Willis, Craig R.G. Basu, R. Witzigreuter, L. Bell, S. Szewczyk, N. Lotz, M.K. Hill, M.
Zhu, S.
Liu, H.
Davis, T.
Willis, Craig R.G.
Basu, R.
Witzigreuter, L.
Bell, S.
Szewczyk, N.
Lotz, M.K.
Hill, M.
Publication Date
2023-07
End of Embargo
Supervisor
Rights
© 2023 The Authors. Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
02/02/2023
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Objective: Many patients with acromegaly, a hormonal disorder with excessive growth hormone (GH) production, report pain in joints. We undertook this study to characterize the joint pathology of mice with overexpression of bovine GH (bGH) or a GH receptor antagonist (GHa) and to investigate the effect of GH on regulation of chondrocyte cellular metabolism.
Methods: Knee joints from mice overexpressing bGH or GHa and wild-type (WT) control mice were examined using histology and micro–computed tomography for osteoarthritic (OA) pathologies. Additionally, cartilage from bGH mice was used for metabolomics analysis. Mouse primary chondrocytes from bGH and WT mice, with or without pegvisomant treatment, were used for quantitative polymerase chain reaction and Seahorse respirometry analyses.
Results: Both male and female bGH mice at ~13 months of age had increased knee joint degeneration, which was characterized by loss of cartilage structure, expansion of hypertrophic chondrocytes, synovitis, and subchondral plate thinning. The joint pathologies were also demonstrated by significantly higher Osteoarthritis Research Society International and Mankin scores in bGH mice compared to WT control mice. Metabolomics analysis revealed changes in a wide range of metabolic pathways in bGH mice, including beta-alanine metabolism, tryptophan metabolism, lysine degradation, and ascorbate and aldarate metabolism. Also, bGH chondrocytes up-regulated fatty acid oxidation and increased expression of Col10a. Joints of GHa mice were remarkably protected from developing age-associated joint degeneration, with smooth articular joint surface.
Conclusion: This study showed that an excessive amount of GH promotes joint degeneration in mice, which was associated with chondrocyte metabolic dysfunction and hypertrophic changes, whereas antagonizing GH action through a GHa protects mice from OA development.
Version
Published version
Citation
Zhu S, Liu H, Davis T et al (2023) Promotion of joint degeneration and chondrocyte metabolic dysfunction by excessive growth hormone in mice. Arthritis & Rheumatology. 75(7): 1139-1151.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article